Ainos Launches VELDONA Pet Cytoprotein Health Supplement Targeting $20M In Sales During 2024
Portfolio Pulse from Happy Mohamed
Ainos, Inc. has launched its VELDONA Pet cytoprotein health supplements, targeting $20 million in sales during 2024. The product will first be marketed in Taiwan in June, with plans to expand sales and marketing in other markets. Ainos aims to capture the lucrative global pet care market, which is projected to grow to over $325 billion in 2028.
May 30, 2023 | 1:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ainos' launch of VELDONA Pet health supplements targets $20 million in sales during 2024, with plans to expand sales and marketing in other markets, potentially boosting the company's revenue.
Ainos' launch of VELDONA Pet health supplements and its plans to expand sales and marketing in other markets could potentially boost the company's revenue. The global pet care market is projected to grow to over $325 billion in 2028, providing a significant opportunity for Ainos to increase its sales and revenue.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100